Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery

Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery

US Patent 10711067 · Granted Jul 14, 2020

Estimated economic value: $2,522,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Extended local release of anti-CSFR1 antibodies2025
Antibodies that bind interleukin-2 and uses thereof2025
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof2023
Targeted delivery of anti-CSF1R antibodies to joints with tenosynovial giant cel2023
Extended local release of anti-CSFR1 antibodies2022
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2022
Antibodies that bind interleukin-2 and uses thereof2020
Parathyroid hormone receptor 1 (PTH1R) antibodies and uses thereof2019
Antibody fragments against the insulin receptor and uses thereof to treat hypogl2019
Antibody fragments against the insulin receptor and uses thereof to treat hypogl2019
Methods for fucoidan purification from seaweed extracts2016